Arcellx, Inc. (ACLX)

68.34 -1.52 (-2.18%) USD  |  NASDAQ  |  Jan 15, 16:00
68.34 0.00 (0.00%) After-Hours: 16:17
More

Arcellx EBITDA Margin Estimates for Current Quarter

EBITDA Margin Estimates for Current Quarter Chart

View EBITDA Margin Estimates for Current Quarter for ACLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin Estimates for Current Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin Estimates for Current Quarter Range, Past 5 Years

View EBITDA Margin Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin Estimates for Current Quarter Benchmarks

View EBITDA Margin Estimates for Current Quarter Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Johnson & Johnson Upgrade
Amicus Therapeutics, Inc. Upgrade
Relmada Therapeutics, Inc. --
Invivyd, Inc. Upgrade